The Duke Pediatric AIDS Clinical Trials Unit is a multicenter program which provides ACTG protocol care to HIV infected and exposed children throughout North Carolina, southern Virginia, and northern South Carolina. To provide these services in a cost-effective, regional approach, the North Carolina Children's AIDS Network (NC-CAN) was created. The core of the network is at Duke, where the largest number of patients are seen, data entry and quality assurance activities are based, and interface occurs with several large basic science programs. There is a full sub-unit at the University of North Carolina at Chapel Hill, which began with a focus on adolescents (because of a large hemophilia center), but has evolved to emphasize perinatal prophylaxis and primary therapy trials. The NC-CAN has two Outreach Clinics, at the Carolinas Medical Center in Charlotte, NC, and the Brenner Children's Hospital at Bowman Gray School of Medicine in Winston-Salem, NC. To serve these clinics, a physician-nurse team from Duke travels to Charlotte and Winston-Salem on a regularly scheduled basis (every 2 to 4 weeks for each site). In the Outreach Clinics, patients are seen by their local pediatric infectious diseases specialist for care, and by the Duke Travel Team for ACTG protocol related issues. Thus, patients can participate in ACTG protocols closer to their local community, making access to cutting edge medical care more easily available for this generally poor and disadvantaged population. The Travel Team also participates in Screening Clinics in Greenville, NC (East Carolina University School of Medicine) and Roanoke, VA (Community Hospital of the Roanoke Valley) where patients are seen and evaluated regarding their suitability for ACTG protocols, again in coordination with their local pediatric infectious diseases specialists. In addition to providing medical care closer to the patients' homes, the NC-CAN model as a whole allows the Duke PACTU to maintain tight quality assurance, since the forms are completed by Duke staff, and to provide Optimum laboratory specimen delivery, since clinical specimens from the Outreach and Screening Clinics are hand delivered to ACTG certified retrovirology and cytometry labs at UNC and Duke (respectively).

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1 (01))
Program Officer
Batzold, Frederick
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Schools of Medicine
United States
Zip Code
Kelly, Matthew S; Crotty, Eric J; Rattan, Mantosh S et al. (2016) Chest Radiographic Findings and Outcomes of Pneumonia Among Children in Botswana. Pediatr Infect Dis J 35:257-62
Thielman, Nathan M; Cunningham, Coleen K; Woods, Christopher et al. (2016) Ebola clinical trials: Five lessons learned and a way forward. Clin Trials 13:83-6
Johnson, Opemipo O; Benjamin, Daniel K; Benjamin Jr, Daniel K et al. (2009) Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania. Pediatr Infect Dis J 28:493-7
Polzer Casarez, Rebecca L; Miles, Margaret Shandor (2008) Spirituality: a cultural strength for African American mothers with HIV. Clin Nurs Res 17:118-32
Benjamin Jr, Daniel K; Miller, Wiliam C; Benjamin, Daniel K et al. (2003) A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV. AIDS 17:2331-6
Fiscus, S A; Brambilla, D; Grosso, L et al. (1998) Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper. J Clin Microbiol 36:258-60
Dyer, J R; Gilliam, B L; Eron Jr, J J et al. (1997) Shedding of HIV-1 in semen during primary infection. AIDS 11:543-5
Fiscus, S A; Royce, R; Eron, J J (1996) Quality control of HIV cultures in a clinical retrovirology laboratory. J Virol Methods 58:91-8
Dyer, J R; Gilliam, B L; Eron Jr, J J et al. (1996) Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J Virol Methods 60:161-70
Scott, W A; Brambilla, D; Siwak, E et al. (1996) Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group. J Clin Microbiol 34:2312-5

Showing the most recent 10 out of 11 publications